Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer

Ítems similars

• Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade
  per: Umelo, Ijeoma Adaku, et al.
  Publicat: (2015)
• Targeting USP13‐mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non‐small cell lung cancer
  per: Giron, Philippe, et al.
  Publicat: (2021)
• Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer
  per: Noor, Alfiah, et al.
  Publicat: (2018)
• Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
  per: Chen Gang, et al.
  Publicat: (2012-03-01)
• Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
  per: Chen, Gang, et al.
  Publicat: (2012)